These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15856080)

  • 1. Nicotine normalizes increased prefrontal cortical dopamine D1 receptor binding and decreased working memory performance produced by repeated pretreatment with MK-801: a PET study in conscious monkeys.
    Tsukada H; Miyasato K; Nishiyama S; Fukumoto D; Kakiuchi T; Domino EF
    Neuropsychopharmacology; 2005 Dec; 30(12):2144-53. PubMed ID: 15856080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys.
    Tsukada H; Nishiyama S; Fukumoto D; Sato K; Kakiuchi T; Domino EF
    Neuropsychopharmacology; 2005 Oct; 30(10):1861-9. PubMed ID: 15841110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D1 dopamine and NMDA receptors interactions in the medial prefrontal cortex: modulation of spatial working memory in rats.
    Rios Valentim SJ; Gontijo AV; Peres MD; Rodrigues LC; Nakamura-Palacios EM
    Behav Brain Res; 2009 Dec; 204(1):124-8. PubMed ID: 19482047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine sensitization of monkey striatal dopamine release.
    Domino EF; Tsukada H
    Eur J Pharmacol; 2009 Apr; 607(1-3):91-5. PubMed ID: 19232339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action.
    López-Gil X; Artigas F; Adell A
    Int J Neuropsychopharmacol; 2009 May; 12(4):487-99. PubMed ID: 18752722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
    Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
    JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of methamphetamine and nicotine on the striatal [(11)C]raclopride binding in unanesthetized monkeys.
    Tsukada H; Miyasato K; Kakiuchi T; Nishiyama S; Harada N; Domino EF
    Synapse; 2002 Sep; 45(4):207-12. PubMed ID: 12125041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior.
    Zuo DY; Zhang YH; Cao Y; Wu CF; Tanaka M; Wu YL
    Life Sci; 2006 Apr; 78(19):2172-8. PubMed ID: 16280137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idazoxan blocks the nicotine-induced reversal of the memory impairment caused by the NMDA glutamate receptor antagonist dizocilpine.
    Timofeeva OA; Levin ED
    Pharmacol Biochem Behav; 2008 Sep; 90(3):372-81. PubMed ID: 18456310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
    Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
    Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance.
    Zahrt J; Taylor JR; Mathew RG; Arnsten AF
    J Neurosci; 1997 Nov; 17(21):8528-35. PubMed ID: 9334425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interhemispheric regulation of the rat medial prefrontal cortical glutamate stress response: role of local GABA- and dopamine-sensitive mechanisms.
    Lupinsky D; Moquin L; Gratton A
    Psychopharmacology (Berl); 2017 Feb; 234(3):353-363. PubMed ID: 27822602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
    Kosowski AR; Liljequist S
    J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptors.
    Catafau AM; Searle GE; Bullich S; Gunn RN; Rabiner EA; Herance R; Radua J; Farre M; Laruelle M
    J Cereb Blood Flow Metab; 2010 May; 30(5):985-93. PubMed ID: 20029452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors.
    Wedzony K; Klimek V; Gołembiowska K
    Brain Res; 1993 Sep; 622(1-2):325-9. PubMed ID: 8242376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat.
    Pietraszek M; Michaluk J; Romańska I; Wasik A; Gołembiowska K; Antkiewicz-Michaluk L
    Neurotox Res; 2009 Nov; 16(4):390-407. PubMed ID: 19649683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
    Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine-induced dopamine release in primates measured with [11C]raclopride PET.
    Marenco S; Carson RE; Berman KF; Herscovitch P; Weinberger DR
    Neuropsychopharmacology; 2004 Feb; 29(2):259-68. PubMed ID: 14666115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA-mediated modulation of dopamine release is modified in rat prefrontal cortex and nucleus accumbens after chronic nicotine treatment.
    Grilli M; Pittaluga A; Merlo-Pich E; Marchi M
    J Neurochem; 2009 Jan; 108(2):408-16. PubMed ID: 19046354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats.
    Harrison AA; Gasparini F; Markou A
    Psychopharmacology (Berl); 2002 Feb; 160(1):56-66. PubMed ID: 11862374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.